These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16162790)

  • 1. Heparin added to cardioplegic solution inhibits tumor necrosis factor-alpha production and attenuates myocardial ischemic-reperfusion injury.
    Pevni D; Frolkis I; Shapira I; Schwartz D; Yuhas Y; Schwartz IF; Chernichovski T; Uretzky G
    Chest; 2005 Sep; 128(3):1805-11. PubMed ID: 16162790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardioplegic ischemia or reperfusion: which is a main trigger for tumor necrosis factor production?
    Pevni D; Frolkis I; Shapira I; Schwartz D; Schwartz I; Chernichovski T; Nesher N; Uretzky G
    Int J Cardiol; 2008 Jul; 127(2):186-91. PubMed ID: 17689703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tumor necrosis factor-alpha improves myocardial recovery after ischemia and reperfusion.
    Gurevitch J; Frolkis I; Yuhas Y; Lifschitz-Mercer B; Berger E; Paz Y; Matsa M; Kramer A; Mohr R
    J Am Coll Cardiol; 1997 Nov; 30(6):1554-61. PubMed ID: 9362416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological preconditioning with monophosphoryl lipid A improves post ischemic diastolic function and modifies TNF-alpha synthesis.
    Sharony R; Frolkis I; Froylich D; Wildhirt SM; Shapira I; Reichart B; Nesher N; Uretzky G
    Eur J Cardiothorac Surg; 2005 Mar; 27(3):501-7. PubMed ID: 15740963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caffeic acid phenethyl ester (CAPE) supplemented St. Thomas' hospital cardioplegic solution improves the antioxidant defense system of rat myocardium during ischemia-reperfusion injury.
    Ozeren M; Sucu N; Tamer L; Aytacoglu B; Bayri O; Döndaş A; Ayaz L; Dikmengil M
    Pharmacol Res; 2005 Sep; 52(3):258-63. PubMed ID: 15890527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of myocardial reperfusion injury by poly(ADP-ribose) synthetase inhibitor, 3-aminobenzamide, in cardioplegic solution: in vitro study of isolated rat heart model.
    Yamazaki K; Miwa S; Ueda K; Tanaka S; Toyokuni S; Unimonh O; Nishimura K; Komeda M
    Eur J Cardiothorac Surg; 2004 Aug; 26(2):270-5. PubMed ID: 15296882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial protection against global ischemia with Krebs-Henseleit buffer-based cardioplegic solution.
    Minasian SM; Galagudza MM; Dmitriev YV; Kurapeev DI; Vlasov TD
    J Cardiothorac Surg; 2013 Apr; 8():60. PubMed ID: 23547937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related changes in the ability of hypothermia and cardioplegia to protect ischemic rabbit myocardium.
    Baker JE; Boerboom LE; Olinger GN
    J Thorac Cardiovasc Surg; 1988 Nov; 96(5):717-24. PubMed ID: 3184966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trace amounts of albumin protect against ischemia and reperfusion injury in isolated rat hearts.
    Watts JA; Maiorano PC
    J Mol Cell Cardiol; 1999 Sep; 31(9):1653-62. PubMed ID: 10471349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protamine-induced cardiotoxicity is prevented by anti-TNF-alpha antibodies and heparin.
    Pevni D; Frolkis I; Iaina A; Wollman Y; Chernichovski T; Shapira I; Paz J; Kramer A; Locker C; Mohr R
    Anesthesiology; 2001 Dec; 95(6):1389-95. PubMed ID: 11748397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Myocardial protection against global ischemia-reperfusion with use of Krebs-Henseleit buffer-based cardioplegic solution].
    Minasian SM; Galagudza MM; Vasil'eva MS; Kurapeev DI; Zaverev DA
    Ross Fiziol Zh Im I M Sechenova; 2010 Apr; 96(4):353-61. PubMed ID: 20564956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental study of intermittent crossclamping with fibrillation and myocardial protection: reduced injury from shorter cumulative ischemia or intrinsic protective effect?
    Bessho R; Chambers DJ
    J Thorac Cardiovasc Surg; 2000 Sep; 120(3):528-37. PubMed ID: 10962415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of the immature myocardium during ischemic arrest: dose dependent effects of glucose and mannitol when added to St Thomas' cardioplegic solution.
    Yang SS; Hearse DJ
    Can J Cardiol; 1989; 5(8):401-7. PubMed ID: 2514036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between paracrine tumor necrosis factor-alpha and paracrine angiotensin II during myocardial ischemia.
    Frolkis I; Gurevitch J; Yuhas Y; Iaina A; Wollman Y; Chernichovski T; Paz Y; Matsa M; Pevni D; Kramer A; Shapira I; Mohr R
    J Am Coll Cardiol; 2001 Jan; 37(1):316-22. PubMed ID: 11153758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement in functional recovery of the isolated guinea pig heart after hyperkalemic reperfusion with adenosine.
    Habazettl H; Palmisano BW; Graf BM; Roerig DL; Bosnjak ZJ; Stowe DF
    J Thorac Cardiovasc Surg; 1996 Jan; 111(1):74-84. PubMed ID: 8551791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-density lipoproteins protect isolated rat hearts from ischemia-reperfusion injury by reducing cardiac tumor necrosis factor-alpha content and enhancing prostaglandin release.
    Calabresi L; Rossoni G; Gomaraschi M; Sisto F; Berti F; Franceschini G
    Circ Res; 2003 Feb; 92(3):330-7. PubMed ID: 12595346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia.
    Lu K; Otani H; Yamamura T; Nakao Y; Hattori R; Ninomiya H; Osako M; Imamura H
    J Thorac Cardiovasc Surg; 2001 Jan; 121(1):137-48. PubMed ID: 11135170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardioprotective effects of the combination of ischemic preconditioning with hypothermia and crystalloid cardioplegia in immature rabbits.
    Zhu SS; Zhang ZM; Zhang YC; Xu PC; Dong HY; Fan JW; Zeng YM
    Sheng Li Xue Bao; 2004 Jun; 56(3):389-96. PubMed ID: 15224156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent.
    Bessho R; Chambers DJ
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):993-1003. PubMed ID: 11689806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isotonic versus hypertonic initial hyperkalemic reperfusion after cardioplegic arrest in isolated hearts.
    Habazettl H; Palmisano BW; Bosnjak ZJ; Graf BM; Stowe DF
    Thorac Cardiovasc Surg; 1995 Jun; 43(3):123-8. PubMed ID: 7570562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.